SREBF1 and metabolic dysfunction-associated steatotic liver disease: Furthermore, when we analysed these genes after stratifying participants by the histology assessment, we demonstrated that those with confirmed MASLD diagnosis had significantly higher relative hepatic expression of SREBP1 and ABCG1 genes compared to the NL group, like it was observed in our previous studies [19,20].